25-28 September 2017 - Takis and Evvivax at the 2nd World Electroporation Congress
Takis and Evvivax presented new data at the 2nd World Electroporation Congress in Norfolk, VA.
Luigi Aurisicchio showed a wealth of data showing that Electroporation is a great technology for electrochemotherapy, DNA Vaccines, Gene therapy, generation of Antibodies, in vivo antibodies synthesis and RNAi. Electroporation has a strong potential for Cancer and Infectious disease innovative therapies. All the most important players in this field were present at the meeting.
"We are proud to be here and present our latest data showing that electroporation-based therapies can be combined and achieve local and systemic tumor control over time" - declared Luigi Aurisicchio, CEO/CSO at Takis and Evvivax.